Trial · NCT01316744
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
NCT01316744, Phase 3, Unknown, University of Glasgow
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain. Trials, record NCT01316744. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01316744
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
- NCT number
- NCT01316744
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 214 participants, estimated
- Lead sponsor
- University of Glasgow
- Conditions
- Cancer
- Interventions
- ketamine hydrochloride, pharmacogenomic studies, questionnaire administration, assessment of therapy complications, quality-of-life assessment
- First posted
- 2011-03-16
- Last updated
- 2011-05-13
- Other registries' IDs
- eudract:2007-002080-27, isrctn:ISRCTN49116945
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to treatment failure | ||
| Secondary | Initial treatment benefit (at day 4 of assessment period of 16 days) using the sensory component of the McGill Short-Form Questionnaire | ||
| Secondary | Difference in overall pain between the study arms based on the visual-analogue score | ||
| Secondary | Difference in neuropathic pain between the study arms based on the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale | ||
| Secondary | Worst pain score (index neuropathic site) in the previous 24 hours (between the two arms) at study baseline and then during study assessment period | ||
| Secondary | Patient distress between the two arms based on NCCN Distress Thermometer | ||
| Secondary | Side effects and tolerability of trial drug | ||
| Secondary | Effect of the intervention on quality-of-life scores (based on Euroqol thermometer), anxiety and depression (based on HAD scale), and opioid requirements |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01316744
GET https://conductscience.org/api/trials/v1/NCT01316744/registered